47
| Company | Price & Valuation | FV & Narrative | Valuation | Growth | Analyst Target | |
|---|---|---|---|---|---|---|
9911 Newborn Town HK$9.26n/aintrinsic discount 12.9%7D 4.6%3M The author hasn't set a fair value for 9911 | ||||||
939 China Construction Bank HK$8.13n/aintrinsic discount 4.5%7D -3.4%3M The author hasn't set a fair value for 939 | ||||||
BDT Bird Construction CA$67.64n/aintrinsic discount 4.3%7D 40.6%3M The author hasn't set a fair value for BDT | ||||||
BETS B Betsson SEK 89.80n/aintrinsic discount 4.0%7D -6.3%3M The author hasn't set a fair value for BETS B | ||||||
MELI MercadoLibre US$1,852.22n/aintrinsic discount 2.6%7D 0.6%3M The author hasn't set a fair value for MELI | ||||||
DKSH DKSH Holding CHF 65.80n/aintrinsic discount 2.5%7D 11.0%3M The author hasn't set a fair value for DKSH | ||||||
LKNC.Y Luckin Coffee US$31.91n/aintrinsic discount 2.2%7D -5.4%3M The author hasn't set a fair value for LKNC.Y | ||||||
BS6 Yangzijiang Shipbuilding (Holdings) S$3.61n/aintrinsic discount 1.4%7D -8.8%3M The author hasn't set a fair value for BS6 | ||||||
999 Xiaocaiyuan International Holding HK$7.09n/aintrinsic discount 1.3%7D 10.4%3M The author hasn't set a fair value for 999 | ||||||
SFNC Simmons First National US$22.86n/aintrinsic discount 0.4%7D 11.1%3M The author hasn't set a fair value for SFNC | ||||||
PNFP Pinnacle Financial Partners US$100.47n/aintrinsic discount 0.2%7D 7.2%3M The author hasn't set a fair value for PNFP | ||||||
MRP Millrose Properties US$28.37n/aintrinsic discount 0%7D -7.9%3M The author hasn't set a fair value for MRP | ||||||
HBAN Huntington Bancshares US$17.87n/aintrinsic discount -0.1%7D 7.7%3M The author hasn't set a fair value for HBAN | ||||||
HRMY Harmony Biosciences Holdings US$36.84n/aintrinsic discount -0.5%7D 25.8%3M The author hasn't set a fair value for HRMY | ||||||
MFC Manulife Financial CA$58.52n/aintrinsic discount -0.5%7D 12.2%3M The author hasn't set a fair value for MFC | ||||||
CCB Coastal Financial US$78.47n/aintrinsic discount -0.6%7D -4.4%3M The author hasn't set a fair value for CCB | ||||||
COLB Columbia Banking System US$32.05n/aintrinsic discount -0.6%7D 10.3%3M The author hasn't set a fair value for COLB | ||||||
MNSO MINISO Group Holding US$11.79n/aintrinsic discount -0.9%7D -26.3%3M The author hasn't set a fair value for MNSO | ||||||
NIC Nicolet Bankshares US$164.08n/aintrinsic discount -1.2%7D 3.6%3M The author hasn't set a fair value for NIC | ||||||
FITB Fifth Third Bancorp US$57.07n/aintrinsic discount -1.4%7D 14.7%3M The author hasn't set a fair value for FITB | ||||||
4206 Aica Kogyo Company JP¥3,680.00n/aintrinsic discount -1.5%7D 2.9%3M The author hasn't set a fair value for 4206 | ||||||
2419 Dekon Food and Agriculture Group HK$49.52n/aintrinsic discount -1.6%7D -33.2%3M The author hasn't set a fair value for 2419 | ||||||
BAER Julius Bär Gruppe CHF 72.76n/aintrinsic discount -2.2%7D 18.5%3M The author hasn't set a fair value for BAER | ||||||
8795 T&D Holdings JP¥4,937.00n/aintrinsic discount -2.3%7D 21.4%3M The author hasn't set a fair value for 8795 | ||||||
AU AngloGold Ashanti US$82.10n/aintrinsic discount -2.3%7D -25.2%3M The author hasn't set a fair value for AU | ||||||
MLYS Mineralys Therapeutics US$28.38n/aintrinsic discount -2.5%7D 3.9%3M The author hasn't set a fair value for MLYS | ||||||
ONC BeOne Medicines US$298.70n/aintrinsic discount -3.5%7D -3.6%3M The author hasn't set a fair value for ONC | ||||||
TPC Tutor Perini US$75.89n/aintrinsic discount -5.0%7D -11.9%3M The author hasn't set a fair value for TPC | ||||||
966 China Taiping Insurance Holdings HK$18.58n/aintrinsic discount -5.9%7D -16.6%3M The author hasn't set a fair value for 966 | ||||||
AGI Alamos Gold CA$41.6942.8% undervalued intrinsic discount -7.1%7D -37.9%3M | ||||||
EMR Emerald Resources AU$5.26n/aintrinsic discount -9.0%7D -14.3%3M The author hasn't set a fair value for EMR | ||||||
RHM Rheinmetall €992.00n/aintrinsic discount -12.2%7D -33.3%3M The author hasn't set a fair value for RHM | ||||||
ALHC Alignment Healthcare US$19.83n/aintrinsic discount -19.3%7D -6.8%3M The author hasn't set a fair value for ALHC |
47
| Company | Price & Valuation | FV & Narrative | Valuation | Growth | Analyst Target | |
|---|---|---|---|---|---|---|
9911 Newborn Town 12.9%7D 4.6%3M | HK$9.26 n/aintrinsic discount | The author hasn't set a fair value for 9911 | PE 12.1x | E 16.7% | HK$13.84 | |
939 China Construction Bank 4.5%7D -3.4%3M | HK$8.13 n/aintrinsic discount | The author hasn't set a fair value for 939 | PE 5.5x | E 5.4% | HK$10.74 | |
BDT Bird Construction 4.3%7D 40.6%3M | CA$67.64 n/aintrinsic discount | The author hasn't set a fair value for BDT | PE 75.8x | E 49.2% | CA$64.75 | |
BETS B Betsson 4.0%7D -6.3%3M | SEK 89.80 n/aintrinsic discount | The author hasn't set a fair value for BETS B | PE 7.1x | E 0.7% | SEK 95.00 | |
EVO Evolution 3.7%7D 12.2%3M | SEK 684.00 n/aintrinsic discount | The author hasn't set a fair value for EVO | PE 11.3x | E 4.3% | SEK 677.14 | |
MONY MONY Group 3.4%7D 18.7%3M | UK£1.96 n/aintrinsic discount | The author hasn't set a fair value for MONY | PE 12.4x | E 7.0% | UK£2.28 | |
HACK Hacksaw 3.3%7D 25.3%3M | SEK 81.00 n/aintrinsic discount | The author hasn't set a fair value for HACK | PE 13.7x | E 24.8% | SEK 105.01 | |
MELI MercadoLibre 2.6%7D 0.6%3M | US$1,852.22 n/aintrinsic discount | The author hasn't set a fair value for MELI | PE 48.9x | E 26.8% | US$2,208.63 | |
DKSH DKSH Holding 2.5%7D 11.0%3M | CHF 65.80 n/aintrinsic discount | The author hasn't set a fair value for DKSH | PE 21.1x | E 8.9% | CHF 74.69 | |
LKNC.Y Luckin Coffee 2.2%7D -5.4%3M | US$31.91 n/aintrinsic discount | The author hasn't set a fair value for LKNC.Y | PE 19.5x | E 22.2% | US$45.77 | |
RUSTA Rusta 2.0%7D -15.4%3M | SEK 85.70 n/aintrinsic discount | The author hasn't set a fair value for RUSTA | PE 23.9x | E 14.7% | SEK 89.33 | |
EXEL Exelixis 1.7%7D 23.2%3M | US$56.50 n/aintrinsic discount | The author hasn't set a fair value for EXEL | PE 17x | E 10.6% | US$50.38 | |
BS6 Yangzijiang Shipbuilding (Holdings) 1.4%7D -8.8%3M | S$3.61 n/aintrinsic discount | The author hasn't set a fair value for BS6 | PE 8.6x | E 9.3% | S$4.59 | |
999 Xiaocaiyuan International Holding 1.3%7D 10.4%3M | HK$7.09 n/aintrinsic discount | The author hasn't set a fair value for 999 | PE 10.1x | E 6.8% | HK$9.06 | |
SFNC Simmons First National 0.4%7D 11.1%3M | US$22.86 n/aintrinsic discount | The author hasn't set a fair value for SFNC | PB 1x | E 113.6% | US$24.14 | |
CS AXA 0.2%7D 5.8%3M | €44.27 n/aintrinsic discount | The author hasn't set a fair value for CS | PE 12.5x | E 6.7% | €48.29 | |
PNFP Pinnacle Financial Partners 0.2%7D 7.2%3M | US$100.47 n/aintrinsic discount | The author hasn't set a fair value for PNFP | PE 24.2x | E 41.3% | US$118.10 | |
AGS ageas 0.07%7D 3.7%3M | €70.75 n/aintrinsic discount | The author hasn't set a fair value for AGS | PE 7.9x | E 2.5% | €67.99 | |
MRP Millrose Properties 0%7D -7.9%3M | US$28.37 n/aintrinsic discount | The author hasn't set a fair value for MRP | PE 10.2x | E 5.5% | US$37.60 | |
HBAN Huntington Bancshares -0.1%7D 7.7%3M | US$17.87 n/aintrinsic discount | The author hasn't set a fair value for HBAN | PE 17.5x | E 15.9% | US$20.45 | |
HRMY Harmony Biosciences Holdings -0.5%7D 25.8%3M | US$36.84 n/aintrinsic discount | The author hasn't set a fair value for HRMY | PE 14.6x | E 19.3% | US$44.91 | |
MFC Manulife Financial -0.5%7D 12.2%3M | CA$58.52 n/aintrinsic discount | The author hasn't set a fair value for MFC | PE 16.5x | E 10.0% | CA$56.05 | |
CCB Coastal Financial -0.6%7D -4.4%3M | US$78.47 n/aintrinsic discount | The author hasn't set a fair value for CCB | PE 24.3x | E 44.2% | US$103.75 | |
COLB Columbia Banking System -0.6%7D 10.3%3M | US$32.05 n/aintrinsic discount | The author hasn't set a fair value for COLB | PE 14.2x | E 12.7% | US$33.31 | |
MNSO MINISO Group Holding -0.9%7D -26.3%3M | US$11.79 n/aintrinsic discount | The author hasn't set a fair value for MNSO | PE 11.7x | E 20.0% | US$19.87 | |
RNST Renasant -1.1%7D 6.8%3M | US$42.52 n/aintrinsic discount | The author hasn't set a fair value for RNST | PE 17.2x | E 22.2% | US$46.43 | |
NIC Nicolet Bankshares -1.2%7D 3.6%3M | US$164.08 n/aintrinsic discount | The author hasn't set a fair value for NIC | PE 26.2x | E 40.2% | US$177.80 | |
FITB Fifth Third Bancorp -1.4%7D 14.7%3M | US$57.07 n/aintrinsic discount | The author hasn't set a fair value for FITB | PE 25.5x | E 22.6% | US$60.80 | |
4206 Aica Kogyo Company -1.5%7D 2.9%3M | JP¥3,680.00 n/aintrinsic discount | The author hasn't set a fair value for 4206 | PE 12.6x | E 5.1% | JP¥4,050.00 | |
2419 Dekon Food and Agriculture Group -1.6%7D -33.2%3M | HK$49.52 n/aintrinsic discount | The author hasn't set a fair value for 2419 | PE 11.5x | E 51.4% | HK$96.93 | |
ADS adidas -1.9%7D 31.9%3M | €181.85 n/aintrinsic discount | The author hasn't set a fair value for ADS | PE 23.2x | E 15.2% | €205.34 | |
BAER Julius Bär Gruppe -2.2%7D 18.5%3M | CHF 72.76 n/aintrinsic discount | The author hasn't set a fair value for BAER | PE 19.5x | E 13.5% | CHF 71.76 | |
8795 T&D Holdings -2.3%7D 21.4%3M | JP¥4,937.00 n/aintrinsic discount | The author hasn't set a fair value for 8795 | PE 17x | E 6.1% | JP¥4,954.00 | |
AU AngloGold Ashanti -2.3%7D -25.2%3M | US$82.10 n/aintrinsic discount | The author hasn't set a fair value for AU | PE 11.9x | E 11.1% | US$118.00 | |
MLYS Mineralys Therapeutics -2.5%7D 3.9%3M | US$28.38 n/aintrinsic discount | The author hasn't set a fair value for MLYS | PB 3.9x | E 56.8% | US$49.00 | |
MRK Merck -2.6%7D 3.0%3M | US$123.54 n/aintrinsic discount | The author hasn't set a fair value for MRK | PE 34.1x | E 20.6% | US$132.33 | |
ONC BeOne Medicines -3.5%7D -3.6%3M | US$298.70 n/aintrinsic discount | The author hasn't set a fair value for ONC | PE 64.7x | E 30.2% | US$415.05 | |
CAMX Camurus -4.3%7D 3.9%3M | SEK 554.50 n/aintrinsic discount | The author hasn't set a fair value for CAMX | PE 48.4x | E 32.5% | SEK 768.13 | |
4042 Tosoh -4.4%7D 13.3%3M | JP¥2,698.00 n/aintrinsic discount | The author hasn't set a fair value for 4042 | PE 20x | E 11.9% | JP¥3,092.22 | |
COPN Cosmo -5.0%7D -32.7%3M | CHF 64.30 n/aintrinsic discount | The author hasn't set a fair value for COPN | PS 10.8x | E 42.0% | CHF 129.40 | |
TPC Tutor Perini -5.0%7D -11.9%3M | US$75.89 n/aintrinsic discount | The author hasn't set a fair value for TPC | PE 51.1x | E 49.6% | US$113.25 | |
966 China Taiping Insurance Holdings -5.9%7D -16.6%3M | HK$18.58 n/aintrinsic discount | The author hasn't set a fair value for 966 | PE 2.6x | E -17.3% | HK$25.23 | |
ARGX argenx -6.1%7D 8.3%3M | €763.80 n/aintrinsic discount | The author hasn't set a fair value for ARGX | PE 36.6x | E 22.1% | €886.67 | |
AGI Alamos Gold -7.1%7D -37.9%3M | CA$41.69 42.8% undervalued intrinsic discount | PE 11.6x | E 17.4% | CA$71.30 | ||
EMR Emerald Resources -9.0%7D -14.3%3M | AU$5.26 n/aintrinsic discount | The author hasn't set a fair value for EMR | PE 34.4x | E 48.2% | AU$7.87 | |
RHM Rheinmetall -12.2%7D -33.3%3M | €992.00 n/aintrinsic discount | The author hasn't set a fair value for RHM | PE 44x | E 30.6% | €1,721.35 | |
ALHC Alignment Healthcare -19.3%7D -6.8%3M | US$19.83 n/aintrinsic discount | The author hasn't set a fair value for ALHC | PS 1x | E 39.5% | US$24.92 |